Rajesh M Patel

Mr. Rajesh Patel is the CEO of In Vitro Diagnostics Division (India Business) of Trivitron Healthcare.

Rajesh has diverse experience in sales, marketing and business development in healthcare segment across various business verticals inclusive of pharmaceuticals, Clinical Research Organizations, Clinical Trials &IVD and Medical devices.

Most recently, Rajesh has served as Business Head (P&L Head) for Agappe Diagnostics. He has previously served at various leadership positions in corporate giants including Pfizer, Cadila Pharmaceuticals, Nicholas Piramal, Vimta labs, Quest Diagnostics, Transasia Bio-Medicals and Meril Diagnostics.

Rajesh has a distinguished track record as an international business leader. He has remarkable exposure of international businesses and has been instrumental in handling multiple deals and business contracts with Foreign Multinationals.

He has a deep understanding of sales, marketing and business development. He has played a vital role in international strategic planning, budgeting, business expansion and new product launches. He has, throughout his stint at various leading corporations, been at the forefront in managing and lading large teams.

In his role as the CEO-IVD (India), Rajesh is committed to developing, maintaining and expanding the flourishing IVD segment of Trivitron Healthcare. He has also demonstrated a strong commitment to ensuring that the highest standards of corporate governance, safety, ethics and compliance are maintained. Rajesh is a particularly avid advocate of developing localized strategies to overcome existing competition.

Rajesh comes with a rich experience of over 30 years and is an MBA from Almeda University, USA.